A team of researchers from LMU, the Technical University of Munich (TUM), and Helmholtz Munich reports a novel method that highlights the potential of artificial DNA structures that, when fitted with ...

Needle-free Injection System - Stratis(R) - was used to deliver Scancell's iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 trial. -- The Scancell ...

PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that results from its Phase 1 proof-of-concept trial evaluating DNA-encoded monoclonal antibodies (DMAbs) for COVID-19 have been published in ...

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company that operates its Healthcare business as EMD Serono in the US and Canada, today shared ...

Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS ...

Monitoring donor-derived cell-free DNA is a noninvasive means of detecting antibody-mediated rejection of a transplanted kidney. Monitoring donor-derived cell-free DNA (dd-cfDNA) in kidney transplant ...